Last updated on September 9, 2024
Aarti Drugs Buyback Record Date is 5 September 2024.
Aarti Drugs was established in the year 1984 and forms part of the USD 1,000 Million Aarti Group of Industries with a robust R&D Division at Tarapur, Maharashtra Industrial Development Corporation (MIDC) in close vicinity to manufacturing locations. The company is engaged in the manufacturing of active pharmaceutical ingredients (APIs), pharmaceutical intermediates, and specialty chemicals. It also produces formulations with its wholly-owned subsidiary, Pinnacle Life Science Private Limited.
Products under APIs include Ciprofloxacin Hydrochloride, Metronidazole, Metformin HCL, Ketoconazole, Ofloxacin, etc. whereas Specialty Chemicals include Benzene Sulphonyl Chloride, Methyl Nicotinate, etc. It is exporting its APIs and specialty chemicals to over 100 countries across the globe.
Aarti Drugs Buyback Record Date, Other Details
| Aarti Drugs Buyback Dates | 11 – 18 September 2024 |
| Aarti Drugs Buyback Price | INR 900 per share |
| Market Price on Buyback Approval | INR 606.35 per share |
| Buyback Premium on Market Price | 48.43% |
| Buyback Offer Size (Shares) | 6,65,000 shares |
| Buyback Offer Size (Amount) | INR 59.85 crore |
| Offer Type | Tender |
| Promoter Participation | Yes |
| Face Value | INR 10 per share |
| Listing At | NSE, BSE |
Aarti Drugs Buyback Dates (Timeline)
| Board Meeting Intimation for Buyback Proposal | 21 August 2024 |
| Buyback Approval Date | 26 August 2024 |
| Public Announcement of Buyback | 27 August 2024 |
| Aarti Drugs Buyback Record Date | 5 September 2024 |
| Buyback Opening Date | 11 September 2024 |
| Buyback Closing Date | 18 September 2024 |
| Cut-off Date to receive completed tender forms by Registrar | 18 September 2024 |
| Verification Date by the Registrar | 19 September 2024 |
| Return of unaccepted shares by Registrar | 25 September 2024 |
| Extinguishment of accepted shares | 7 October 2024 |
Aarti Drugs Buyback 2024 Documents
Letter of Offer
Public Announcement
Board Approval
Upcoming Share Buyback
Aarti Drugs Buyback Entitlement Ratio
| Shareholder Category | Entitlement Ratio | Entitlement Ratio (in %) |
| Small Shareholders (less than INR 2 Lakh on record date) | 9/706 | 1.27 |
| General category (for all other Eligible Shareholders) | 5/744 | 0.67 |
Small Shareholder is defined as shareholder who holds shares worth less than INR 2,00,000 as on record date.
Aarti Drugs Financial Performance
| FY 2022 | FY 2023 | FY 2024 | |
| Revenue | 2,251.17 | 2,497.97 | 2,266.91 |
| Total Expenses | 1,953.05 | 2,248.10 | 2,030.94 |
| Net income | 195.00 | 152.81 | 141.88 |
Calculation of Investment in Buyback
| Maximum market value of a share holder as on record date | INR 2,00,000 |
| Buyback price per share | INR 900 |
| Maximum shares for small shareholders (2,00,000/900) | 223 shares * |
| Closing price of stock as on 26 August 2024 | INR 606.35** |
| Maximum amount invested in buyback (INR 606.35 x 223 shares) | INR 1,35,216.05 |
** For simplicity, we have considered price on buyback approval date
Aarti Drugs Buyback Acceptance Ratio
| Shares Tendered | Buyback Entitlement | Acceptance ratio | Buyback Profit | Profit in % |
| 223 | 3 | 3 (100%) | 881 | 0.65 |
| 223 | 3 | 6 (200%) | 1,762 | 1.30 |
| 223 | 3 | 9 (300%) | 2,643 | 1.95 |
Registrar of Aarti Drugs Buyback 2024
LINK INTIME INDIA PRIVATE LIMITED
C-101, 1st Floor, 247 Park L.B.S. Marg,
Vikhroli West, Mumbai – 400 083, Maharashtra
Telephone:Â +91 810 911 4949
Email:Â [email protected]
Website:Â www.linkintime.co.in
Manager of Aarti Drugs Buyback 2024
INGA VENTURES PRIVATE LIMITED
1229, Hubtown Solaris, N.S. Phadke Marg,
Opp. Telli Galli, Andheri (East), Mumbai 400069
Telephone:Â 022 268540808
Email:Â [email protected]
Website:Â www.ingaventures.com
Process to Participate in Aarti Drugs Buyback
All eligible shareholders of the company who own shares in the physical or demat form on the record date may participate in the buyback offer through their stockbroker. The eligible shareholders who hold the shares in demat form must notify their brokers of the details of the equity shares that they wish to tender in the buyback offer.
The shareholder must transfer the tendered shares to the clearing corporation’s Special account. In turn, the broker would place a buyback order on the stock exchange.
The eligible shareholders who own the shares in physical form must present their broker with the original share certificates and supporting documents. After document verification is complete, the broker places an order on the stock exchange and submits the original share certificate and TRS (Transaction Registration Slip) to the registrar.
Frequently Asked Questions
What are Aarti Drugs’ buyback dates?
Aarti Drugs’ share buyback opens on 11 September 2024 and closes on 18 September 2024.
Which type of is Aarti Drugs buyback offer?
Aarti Drugs buyback is a tender offer.
What is Aarti Drugs’ buyback price?
Aarti Drugs’ buyback price is INR 900 per share.
What is Aarti Drugs buyback record date?
Aarti Drugs buyback record date is 5 September 2024.
How to participate in Aarti Drugs share buyback?
Aarti Drugs share buyback will be conducted through the tender process and investors who hold the shares on record date can place orders through their broker.
